Two Sigma Investments’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
QF
O
SCM
ACP
ACA
KCA
SL
YF
VCM
ACA
Two Sigma Investments's WHWK Position: Q1 2026 in Review
Two Sigma Investments reduced its Whitehawk Therapeutics (WHWK) stake by 12% in Q1 2026, selling an estimated $114K and leaving 273,482 shares worth $944K. The position accounts for ﹤0.01% of the portfolio, ranked #3304.
Two Sigma Investments first reported a position in WHWK in Q2 2019 and has held it in 10 quarters since. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.
- Two Sigma Investments held 273,482 shares of Whitehawk Therapeutics worth $944K as of Q1 2026.
- Two Sigma Investments sold 36,383 Whitehawk Therapeutics shares in Q1 2026, an estimated $114K.
- Whitehawk Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3304 holding.
- Two Sigma Investments first reported a position in Whitehawk Therapeutics in Q2 2019 and has held it in 10 quarters since.
- 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.